Alyeska Investment Group, L.P. Clene Inc. Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.31 - $0.44 $62,257 - $88,366	-200,832 Reduced 42.36%	273,298 $98,000
Q1 2024 May 15, 2024	SELL	$0.28 - $0.53 $339,572 - $642,762	-1,212,760 Reduced 71.89%	474,130 $203,000
Q4 2023 Feb 14, 2024	SELL	$0.26 - $0.55 $74,423 - $157,434	-286,245 Reduced 14.51%	1,686,890 $506,000
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.22 $1.54 Million - $2.41 Million	1,973,135 New	1,973,135 $1.74 Million

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $273M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.